Diffuse large B-cell lymphoma remodels the fibroblastic reticular network that acquires aberrant immunosuppressive capabilities; implications for the regulation of anti-tumor immunity in the immuno-oncology era.

被引：0

作者：

Apollonio, B. ^{[1
]}

Jarvis, P. ^{[1
]}

Phillips, E. ^{[1
]}

Kuhnl, A. ^{[2
]}

Salisbury, J. ^{[2
]}

Zacharioudakis, G. ^{[3
]}

Sutton, L. -A. ^{[4
]}

Rosenquist, R. ^{[4
]}

Jarrett, R. ^{[5
]}

Amini, R. -M. ^{[6
]}

Vardi, A. ^{[7
,8
,9
]}

Ramsay, A. ^{[1
]}

机构：

[1] Kings Coll London, Fac Life Sci & Med, London, England

[2] Kings Coll Hosp NHS Fdn Trust, London, England

[3] Aristotle Univ Thessaloniki, Surg Dept 5, Thessaloniki, Greece

[4] Karolinska Inst, Stockholm, Sweden

[5] MRC Univ Glasgow, Glasgow, Lanark, Scotland

[6] Uppsala Univ, Uppsala, Sweden

[7] CERTH, Inst Appl Biosci, Thessaloniki, Greece

[8] G Papanikolaou Hosp, Hematol Dept, Thessaloniki, Greece

[9] G Papanikolaou Hosp, HCT Unit, Thessaloniki, Greece

来源：

关键词：

DLBCL; Immunosuppression; Immunotherapy; Stroma; Tumor Microenvironment;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH19-OR-0

引用

页码：26 / 26

页数：1